Chennai: MSD Pharmaceuticals Pvt. Ltd, a wholly owned subsidiary of Merck Sharp & Dohme, has announced the launch of ‘India’s first’ gender-neutral HPV vaccine- Gardasil 9.
According to a statement, the 9-valent Human Papillomavirus (Types 6, 11, 16,18, 31, 33, 45, 52 and 58 ) Vaccine, will help reduce the diseases burden and cancers caused by the HPV types contained in the vaccine, among Indian girls and women (9-26 years) and Indian boys (9‐15 years).
According to ‘World Population Prospects: The 2015 revision’ database of United Nations Population Division, India has the world’s highest number of 10 to 24-year-olds, which stands at almost 229 million.